January 29, 2015 4:47 AM ET


Company Overview of MedImmune Vaccines, Inc.

Company Overview

MedImmune Vaccines, Inc. is a biopharmaceutical company that provides product development and commercialization of vaccines. The company offers investigational live virus vaccine, which is delivered as a nasal mist for the prevention of influenza. The company was formerly known as Aviron, Inc. and changed its name to MedImmune Vaccines, Inc. in January, 2002. The company was incorporated in 1992 and is based in Mountain View, California. As of January 15, 2002, MedImmune Vaccines, Inc. operates as a subsidiary of MedImmune, LLC.

297 North Bernardo Avenue

Mountain View, CA 94043

United States

Founded in 1992

462 Employees





Key Executives for MedImmune Vaccines, Inc.

Age: 57
Senior Vice President - Operations
Age: 63
Director and Member - Scientific Advisory Board
Age: 85
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
Product Quest Manufacturing, LLC United States
Apex Energetics Inc. United States
Konova Inc. United States
Sustainable Community Development, L.L.C. United States
Essential Resources, Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MedImmune Vaccines, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.